Jay S. Pepose

Ophthalmology

1815 Clarkson Rd
Chesterfield, MO 63017

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances.

LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances.

Journal: American journal of ophthalmology

Published: October 06, 2025

Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.

Reversal of Pharmacologic Mydriasis in Pediatric Subjects with Ryzumvi (0.75% Phentolamine Ophthalmic Solution): A Post-Hoc Pooled Analysis from Three Randomized, Placebo-Controlled Phase 3 Trials.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: August 27, 2025

Reply.

Reply.

Journal: Ophthalmology

Published: March 31, 2025

Assessing Ocular Dominance: Rethinking the Current Paradigm.

Assessing Ocular Dominance: Rethinking the Current Paradigm.

Journal: Journal of cataract and refractive surgery

Published: September 07, 2024

Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution.

Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution.

Journal: Ophthalmology

Published: March 18, 2024

A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.

A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.

Journal: BMC ophthalmology

Published: December 17, 2021

Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.

Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.

Journal: BMC ophthalmology

Published: May 17, 2021

Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial.

Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial.

Journal: Optometry and vision science : official publication of the American Academy of Optometry

Published: February 26, 2021

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.

Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: September 12, 2020

Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique.

Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: June 18, 2020

ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease.

ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: October 10, 2019

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States.

Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: October 05, 2019

Showing 1-12 of 44

Last Updated: 09/26/2026